These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 29669714

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differential Enantiomer-Specific Signaling of Cannabidiol at CB1 Receptors.
    Bosquez-Berger T, Wilson S, Iliopoulos-Tsoutsouvas C, Jiang S, Wager-Miller J, Nikas SP, Mackie KP, Makriyannis A, Straiker A.
    Mol Pharmacol; 2022 Dec; 102(6):259-268. PubMed ID: 36153039
    [Abstract] [Full Text] [Related]

  • 3. Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model.
    Straiker A, Mitjavila J, Yin D, Gibson A, Mackie K.
    Pharmacol Res; 2015 Sep; 99():370-6. PubMed ID: 26211948
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes.
    Navarro G, Reyes-Resina I, Rivas-Santisteban R, Sánchez de Medina V, Morales P, Casano S, Ferreiro-Vera C, Lillo A, Aguinaga D, Jagerovic N, Nadal X, Franco R.
    Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enantiomer-specific positive allosteric modulation of CB1 signaling in autaptic hippocampal neurons.
    Mitjavila J, Yin D, Kulkarni PM, Zanato C, Thakur GA, Ross R, Greig I, Mackie K, Straiker A.
    Pharmacol Res; 2018 Mar; 129():475-481. PubMed ID: 29158048
    [Abstract] [Full Text] [Related]

  • 8. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling.
    Fogaça MV, Campos AC, Coelho LD, Duman RS, Guimarães FS.
    Neuropharmacology; 2018 Jun; 135():22-33. PubMed ID: 29510186
    [Abstract] [Full Text] [Related]

  • 9. Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease.
    Laprairie RB, Bagher AM, Kelly ME, Denovan-Wright EM.
    Mol Pharmacol; 2016 Mar; 89(3):364-75. PubMed ID: 26700564
    [Abstract] [Full Text] [Related]

  • 10. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
    McPartland JM, Duncan M, Di Marzo V, Pertwee RG.
    Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors.
    Navarro G, Varani K, Lillo A, Vincenzi F, Rivas-Santisteban R, Raïch I, Reyes-Resina I, Ferreiro-Vera C, Borea PA, Sánchez de Medina V, Nadal X, Franco R.
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [Abstract] [Full Text] [Related]

  • 12. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors.
    Stern CAJ, da Silva TR, Raymundi AM, de Souza CP, Hiroaki-Sato VA, Kato L, Guimarães FS, Andreatini R, Takahashi RN, Bertoglio LJ.
    Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373
    [Abstract] [Full Text] [Related]

  • 13. Metabotropic suppression of excitation in murine autaptic hippocampal neurons.
    Straiker A, Mackie K.
    J Physiol; 2007 Feb 01; 578(Pt 3):773-85. PubMed ID: 17110416
    [Abstract] [Full Text] [Related]

  • 14. Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue.
    Ryan D, Drysdale AJ, Pertwee RG, Platt B.
    Eur J Neurosci; 2007 Apr 01; 25(7):2093-102. PubMed ID: 17419758
    [Abstract] [Full Text] [Related]

  • 15. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG.
    Br J Pharmacol; 2008 Jan 01; 153(2):199-215. PubMed ID: 17828291
    [Abstract] [Full Text] [Related]

  • 16. Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB2 receptor.
    Bouma J, Broekhuis JD, van der Horst C, Kumar P, Ligresti A, van der Stelt M, Heitman LH.
    Biochem Pharmacol; 2023 Dec 01; 218():115924. PubMed ID: 37972874
    [Abstract] [Full Text] [Related]

  • 17. Molecular Mechanism and Cannabinoid Pharmacology.
    Schurman LD, Lu D, Kendall DA, Howlett AC, Lichtman AH.
    Handb Exp Pharmacol; 2020 Dec 01; 258():323-353. PubMed ID: 32236882
    [Abstract] [Full Text] [Related]

  • 18. Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia.
    Osborne AL, Solowij N, Babic I, Lum JS, Newell KA, Huang XF, Weston-Green K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec 20; 95():109666. PubMed ID: 31202911
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.